Sigma Planning Corp’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,618
Closed -$232K 939
2018
Q2
$232K Buy
9,618
+798
+9% +$19.2K 0.02% 764
2018
Q1
$256K Buy
+8,820
New +$256K 0.02% 665